MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics |
| August 26, 2020 | August 2020 Bond Updates |
|
FOSTER CITY, California, Aug. 26, 2020 /PRNewswire/ -- MedGenome, a leading genomic diagnostics, research and data company based in Foster City, CA and Bangalore, India, today announced that it has formed a strategic discovery collaboration focused on novel discoveries in Parkinson's... |
| View more at: https://www.prnewswire.com:443/news-releases/medgenome-announces-strategic-collaboration-in-parkinsons-disease-with-denali-therapeutics-301118312.html |
| Related News |